| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHOR
|
5,566.00 | 720.8B | 6.25 | 3.29 | 4.34 | 38.0% | 34.4% | 42 | 38 | 3,879.17 | -21.8% | 63 | 1.25 |
|
AKRN
|
18,016.00 | 662.2B | 9.23 | 4.99 | 7.42 | 53.3% | 39.5% | 39 | 35 | 8,266.33 | -40.6% | 86 | 0.55 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.